These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 21785099

  • 21. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors.
    Choi D, Lim HK, Joh JW, Kim SJ, Kim MJ, Rhim H, Kim YS, Yoo BC, Paik SW, Park CK.
    Ann Surg Oncol; 2007 Dec; 14(12):3510-8. PubMed ID: 17653800
    [Abstract] [Full Text] [Related]

  • 22. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D.
    Digestion; 2007 Dec; 75(2-3):104-12. PubMed ID: 17598962
    [Abstract] [Full Text] [Related]

  • 23. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.
    Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, Isaji S, Shiraki K, Fuke H, Uemoto S, Takeda K.
    Radiology; 2008 Apr; 247(1):260-6. PubMed ID: 18305190
    [Abstract] [Full Text] [Related]

  • 24. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 25. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 26. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ, Lee JW, Lee OH, Chung HJ, Kim YS, Lee JI, Cho SG, Jeon YS, Lee KY, Ahn SI, Shin WY.
    J Gastroenterol Hepatol; 2014 May 01; 29(5):1056-64. PubMed ID: 24372785
    [Abstract] [Full Text] [Related]

  • 27. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 28. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 29. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
    Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI.
    Cardiovasc Intervent Radiol; 2014 Jun 23; 37(3):705-15. PubMed ID: 23912493
    [Abstract] [Full Text] [Related]

  • 30. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
    Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K.
    Cancer; 2010 Dec 01; 116(23):5452-60. PubMed ID: 20672352
    [Abstract] [Full Text] [Related]

  • 31. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, Huo L, Zhang XP, Xing BC.
    AJR Am J Roentgenol; 2006 May 01; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Transarterial chemoembolization as first-line therapy for hepatocellular carcinomas infeasible for ultrasound-guided radiofrequency ablation: a retrospective cohort study of 116 patients.
    Song YG, Shin SW, Cho SK, Choi D, Rhim H, Lee MW, Kim YS, Park KB, Park HS, Choo SW, Do YS, Choo IW, Hyun D.
    Acta Radiol; 2015 Jan 01; 56(1):70-7. PubMed ID: 24518688
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec 01; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 36. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K.
    Oncol Rep; 2004 Jan 01; 11(1):105-9. PubMed ID: 14654911
    [Abstract] [Full Text] [Related]

  • 37. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM, Wang JH, Zhen ZJ, Chen HW, Cui WZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 01; 26(11):1626-8. PubMed ID: 17121718
    [Abstract] [Full Text] [Related]

  • 38. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep 01; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 39. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
    Min JH, Lee MW, Cha DI, Jeon YH, Shin SW, Cho SK, Rhim H, Lim HK.
    Korean J Radiol; 2013 Sep 01; 14(2):248-58. PubMed ID: 23483753
    [Abstract] [Full Text] [Related]

  • 40. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
    Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI.
    Radiology; 2014 Mar 01; 270(3):900-9. PubMed ID: 24475823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.